Table 3.
Drug-related ocular TEAEs prior to rescue medication
LE gel (n = 206) | Vehicle (n = 201) | |
---|---|---|
Patients with at least one related AE | 5 (2.4%) | 15 (7.5%) |
Total drug-related AEs | 5 | 17 |
Eye pain | 1 (0.5%) | 3 (1.5%) |
Foreign body sensation | 1 (0.5%) | 3 (1.5%) |
Dry eye | 1 (0.5%) | 1 (0.5%) |
Eye irritation | 1 (0.5%) | 2 (1.0%) |
Ocular hyperemia | 0 | 2 (1.0%) |
Photophobia | 0 | 1 (0.5%) |
Punctate keratitis | 0 | 1 (0.5%) |
Increased lacrimation | 1 (0.5%) | 0 |
Ocular discomfort | 0 | 2 (1.0%) |
Blurred vision | 0 | 1 (0.5%) |
IOP increased | 0 | 1 (0.5%) |
Abbreviations: LE, loteprednol etabonate; TEAE, treatment-emergent adverse event; IOP, intraocular pressure.